Market Pulse Archives

Oct. 18, 2021, 3:47 a.m. EDT

Valneva shares jump 30% after saying vaccine candidate outperformed AstraZeneca's

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    Valneva SE (VLA)
  • X
    AstraZeneca PLC (AZN)

or Cancel Already have a watchlist? Log In

By Steve Goldstein

Valneva /zigman2/quotes/202377434/delayed FR:VLA -1.62% shares jumped 30% in Paris trading after saying its coronavirus vaccine candidate outperformed AstraZeneca's /zigman2/quotes/203048482/delayed UK:AZN -1.09% in a Phase 3 study, which met both its co-primary endpoints. Valneva said its vaccine had a neutralizing antibody seroconversion rate above 95% and that it had a better tolerability profile.

/zigman2/quotes/202377434/delayed
FR : France: Euronext Paris
28.02
-0.46 -1.62%
Volume: 4.15M
Nov. 30, 2021 5:35p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
€2.99 billion
Rev. per Employee
N/A
loading...
/zigman2/quotes/203048482/delayed
UK : U.K.: London
8,276.00 p
-91.00 -1.09%
Volume: 3.66M
Nov. 30, 2021 4:35p
P/E Ratio
88.15
Dividend Yield
2.44%
Market Cap
£129.62 billion
Rev. per Employee
£282,763
loading...

This Story has 0 Comments
Be the first to comment
More News In
Markets

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.